Robertson Stephens Wealth Management »

Cytomx Therapeutics shares owned by Robertson Stephens Wealth Management

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Robertson Stephens Wealth Management from 13F filings

Historical chart of Robertson Stephens Wealth Management investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Robertson Stephens Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Robertson Stephens Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $360k 96k 3.75

More positions owned by Robertson Stephens Wealth Management

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Specialized Funds Div App Etf (VIG)
Apple (AAPL)
Applovin Corp Com Cl A (APP)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
NVIDIA Corporation (NVDA)
Ishares Tr Rus Mid Cap Etf (IWR)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Robertson Stephens Wealth Management

Top funds holding Cytomx Therapeutics

FMR
Kynam Capital Management
BlackRock
Bank of America Corporation
Perceptive Advisors
Vanguard Capital Management
Point72 Asset Management
State Street Corporation
Wellington Management Company
VR Adviser
Baker Bros. Advisors
Geode Capital Management
Elmind Capital
Nextech Invest
Two Sigma Investments

View all funds holding Cytomx Therapeutics